Skip to main content

Animations

MJFF Publications

3921 - 3930 of 6564 Results
Title
Year
  • Year
  • 2026
  • 2025
  • 2026
  • 2025
  • 2025
  • 2026
  • 2025
  • 2014
  • 2015
  • 2023
  • Summary Details
    OPEN
    Title: SNCA-targeted transcriptional repression therapy alleviates pathological and behavioral perturbations in a Parkinson's disease mouse model
    Journal Name: Neurotherapeutics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.neurot.2026.e01049
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Gene therapy device-based delivery of progranulin, prosaposin, and GDNF as a combined precision and neurorestorative therapy in the rat 6-OHDA model of parkinsonism
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2025.115474
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Experiences of Pacific Peoples and their ‘āiga/kāinga/kāiga/vuvale living with Parkinsons: A qualitative study
    Journal Name: PLOS One
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0355989
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Biallelic NDUFA9 variants cause a progressive neurodevelopmental disorder with prominent dystonia and mitochondrial complex I deficiency
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcaf369
    Citation Count: 1
  • Summary Details
    OPEN
    Title: The effect of polygenic risk score on PD risk and phenotype in LRRK2 G2019S and GBA1 carriers
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/1877718x241310722
    Citation Count: 11
  • Summary Details
    OPEN
    Title: LRRK2 G2019S variant is associated with transcriptional changes in Parkinson’s disease human myeloid cells under proinflammatory environment
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-026-03967-0
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Parkinson’s disease mutant Miro1 causes mitochondrial dysfunction and dopaminergic neuron loss
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awaf051
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Refined phosphopeptide enrichment by phosphate additive and the analysis of human brain phosphoproteome
    Journal Name: PROTEOMICS
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/pmic.201400171
    Citation Count: 68
  • Summary Details
    OPEN
    Title: Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.246
    Citation Count: 202
  • Summary Details
    OPEN
    Title: Prodromal dementia with Lewy bodies in REM sleep behavior disorder: A multicenter study
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.13386
    Citation Count: 44
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.